Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29,754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amplified antitumor efficacy by a targeted drug retention and chemosensitization strategy-based "combo" nanoagent together with PD-L1 blockade in reversing multidrug resistance.
Jiang W, Su L, Ao M, Guo X, Cheng C, Luo Y, Xie Z, Wang X, Wang J, Liu S, Cao Y, Li P, Wang Z, Ran H, Zhou Z, Ren J. Jiang W, et al. Among authors: guo x. J Nanobiotechnology. 2021 Jul 5;19(1):200. doi: 10.1186/s12951-021-00947-9. J Nanobiotechnology. 2021. PMID: 34225744 Free PMC article.
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy.
Tang R, He H, Lin X, Wu N, Wan L, Chen Q, Hu Y, Cheng C, Cao Y, Guo X, Zhou Y, Xiong X, Zheng M, Wang Q, Li F, Zhou Y, Li P. Tang R, et al. Among authors: guo x. J Immunother Cancer. 2023 Jan;11(1):e006226. doi: 10.1136/jitc-2022-006226. J Immunother Cancer. 2023. PMID: 36650023 Free PMC article.
29,754 results
You have reached the last available page of results. Please see the User Guide for more information.